ModifiedCapital BluecrossPolicy MP 2.092

Cranial Electrotherapy Stimulation and Auricular Electrostimulation

This policy defines Capital Blue Cross's coverage stance on cranial electrotherapy stimulation (CES) and electrical stimulation of auricular acupuncture points for medical and behavioral health indications; it applies to applicable Capital Blue Cross products and providers.

Policy Summary

PayerCapital Bluecross

PolicyCranial Electrotherapy Stimulation and Auricular Electrostimulation

Policy CodePolicy MP 2.092

Change TypeTitle revisedPENFS moved to MP 2.397IB-stim MN criteria addedcoding updates

Effective DateJan 1, 2026

Next Review Date

Key ActionVerify member benefits and prior authorization requirements and confirm investigational codes are not covered before billing.

SourceLink

POLICY UPDATE CHANGES

Title changed and previously included Percutaneous Electrical Nerve Field Stimulation (PENFS) removed and placed into new policy MP 2.397; trigeminal nerve statement and code removed as addressed in MP 6.020.

Added medical necessity (MN) criteria for the IB-stim device.

New procedure and HCPCS codes (A4543, E0721) were added effective 10/01/2024 and included in coding updates.

investigationalCES stance

investigationalAuricular stance

multipleDevices summarized

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

Coverage Criteria and Determinations

Not medically necessary / Investigational

Policy coverage determinations

CES investigational: Cranial electrotherapy stimulation is investigational in all situations due to insufficient evidence of benefit.

Supported by systematic reviews and small randomized trials showing inconsistent or marginal results across pain, psychiatric, and other indications (see evidence summary).

Auricular electrostimulation investigational: Electrical stimulation of auricular acupuncture points is investigational in all situations due to insufficient evidence of benefit.

Available trials are small, heterogeneous, and have methodological limitations across pain, obesity, and opioid withdrawal indications.

Coverage determinations by indication

Coverage conclusions based on available evidence:

Auricular electrostimulation for acute or chronic pain: Evidence is limited, inconsistent, and methodologically limited; insufficient evidence to determine effects on health outcomes.

Includes small trials in postoperative pain, chronic low back pain, cervical pain, osteoarthritis, and rheumatoid arthritis with varied comparators and outcomes.

Auricular electrostimulation for obesity: Small randomized trials report inconsistent results with variable protocols; evidence is insufficient to determine effects on health outcomes.

Systematic reviews of auricular/acupoint stimulation show heterogenous interventions and outcomes.

Auricular electrostimulation for opioid withdrawal: Evidence includes case series reporting positive outcomes but lacks comparators and uses different protocols; insufficient evidence to determine effects on health outcomes.

Two case series described; methodological limitations preclude definitive conclusions.

Cranial electrotherapy stimulation for depression, anxiety, pain, insomnia, and other indications: Multiple small RCTs, systematic reviews, and meta-analyses exist but results are inconsistent and methodological limitations persist; overall evidence is insufficient for broad coverage except where specific device-level medical necessity criteria have been added in this policy update.

Pooled analyses found marginal benefit for some headaches but no benefit for chronic pain; trials for depression/anxiety report inconsistent outcomes and heterogeneous protocols.

This policy designates both cranial electrotherapy stimulation (CES) and electrical stimulation of auricular acupuncture points as investigational in all situations. The determination is based on insufficient and inconsistent evidence that does not support a general conclusion of benefit for these interventions across the range of evaluated medical and behavioral health indications.

Devices and procedure codes that are listed as investigational in this policy are excluded from coverage. The codes identified under the Investigational; therefore, not covered list should be treated as not covered unless member benefits explicitly state otherwise.

Cranial electrotherapy stimulation (CES) and auricular electrostimulation are specifically considered investigational for all indications. This investigational designation applies regardless of the clinical condition being treated (for example, pain, insomnia, depression, anxiety, obesity, or opioid withdrawal).

Services and devices that are designated Investigational; therefore, not covered in the coding table are considered not medically necessary for coverage purposes and may be denied if submitted for reimbursement.

Codes and Device Listings

FDA product codes and device listings (informational)mixed

QJQ	FDA product code for CES devices (as listed)

Investigational; therefore, not coveredmixedNot Covered

A4543	Investigational; therefore, not covered (listed)
A4596	Procedure code listed as investigational
E0721	Procedure code listed as investigational
E0732	Procedure code listed as investigational
S8930	Procedure code listed as investigational
0783T	Procedure code listed as investigational
64999	Unlisted procedure code listed as investigational

Coding note — coverage determination

Coding identification disclaimerThe listing of a code in this policy does not denote coverage; final coverage determinations are made according to member benefit terms.

Code list completenessThe code list may not be all-inclusive and codes are subject to change at any time.

Reimbursement noteNot all covered services are eligible for separate reimbursement.

Provider Responsibilities and Billing Notes

Prior Authorization

Verify product-level coverage / Prior Authorization

Verify product-level coverage and prior authorization requirements before providing services. Coverage and prior authorization rules vary by product and benefit plan; contact Capital Blue Cross Provider Services or check the member's benefit information for eligibility, benefit limits, and prior authorization requirements.

Confirm member eligibility and benefit details on the date of service.
Obtain prior authorization when required by the member's specific product before scheduling services.

Prior Authorization

Investigational codes — prior authorization / coverage check

Codes and devices listed as investigational are subject to noncoverage. Providers should verify whether submitted codes require prior authorization or are excluded for the member's product before billing.

Investigational codes listed in this policy (see coding information) may not be covered and may require prior authorization or may be denied if billed.
Contact Provider Services or review the member's benefit plan for any product-specific investigational code handling.

Definitions and Device Descriptions

Cranial electrotherapy stimulation (CES)

DefinitionCranial electrotherapy stimulation (CES): delivery of pulsed, low-intensity electrical current to the earlobes, mastoid processes, scalp, or other head sites to modulate brain network activity (hypothalamus, limbic system, reticular activating system).

Common device exampleAlpha-Stim CES — clip electrodes attaching to the earlobes delivering pulsed, low-intensity current.

Other electrode placementsElectrodes may be placed on eyelids, frontal scalp, mastoid processes, or behind the ears depending on device design.

Indications under evaluationCES has been evaluated for pain, insomnia, depression, anxiety, weight loss, and opioid withdrawal.

Auricular electrostimulation

Definition

Modalities Covered in This Policy

CES and auricular electrostimulation

Summaries for both modalities

CES and auricular electrostimulation overall stance: Both cranial electrotherapy stimulation (CES) and electrical stimulation of auricular acupuncture points are considered investigational in all situations due to insufficient evidence to determine their effects on health outcomes.

Evidence base comprises small randomized trials, pooled analyses, systematic reviews, and case series with heterogeneous populations and protocols leading to inconsistent results.

Cranial Electrotherapy Stimulation (CES)

Cranial electrotherapy stimulation (CES) investigational: Cranial electrotherapy stimulation is investigational for all indications due to insufficient and inconsistent evidence from small randomized trials and pooled analyses.

Trials include studies of pain, headache, depression, anxiety, Parkinson disease, smoking cessation, and functional constipation; pooled analyses show marginal or no benefits and heterogeneity limits conclusions.

Background and Rationale

Cranial electrotherapy stimulation (CES) delivers low‑intensity, pulsed electrical current to the earlobes, mastoid processes, or scalp using devices cleared for marketing by FDA (examples include Alpha-Stim and similar). Proposed mechanisms include modulation of central nervous system activity—such as effects on hypothalamic, limbic, and reticular activating system structures—to alter pain perception, arousal, mood, or sleep. Auricular electrostimulation targets acupuncture points on the ear using ambulatory devices (for example, single‑use P‑Stim type devices) that apply programmed electrical stimulation over hours to days.